0 item $0
view cart | checkout

Share Information


Dyesol Limited (ASX: DYE) (FWB: D5I) is an Australian 'clean-tech' company focused on commercialising a third generation solar technology known as Perovskite Solar Cells (PSC). 

Dyesol is a publicly listed company with shares traded in Australia on the ASX and in Germany on the German Open Market.

Investor Brief

For more information about Dyesol, including a brief history and recent milestones, download a copy of our latest Dyesol's Investor Brief.

Top 20 Shareholders

Dyesol is proud to have a large and geographically diverse shareholder base. Learn more about Dyesol's shareholder base by reviewing the Top 20 Shareholders list published monthly.

Trading

 

 

asx

Borse Hamburg

AUSTRALIA

ASX Code: DYE

GERMANY

FWB Code: D5I


Share Registry

Computershare Investor Services Pty Ltd
Level 2, Reserve Bank Building
45 St George's Terrace
Perth, Western Australia 6000

Telephone:  +61 8 9323 2000
Fax:  +61 8 9323 2033
Visit Website >>


XETRA | Deutche Boerse Group

Dyesol Ltd.
Equity
ISIN: AU000000DYE9
WKN A0ETN7
Code:  D5I

Stock Exchange LT Tradegate

Stock Exchange Frankfurt

Stock Exchange Berlin

Stock Exchange Hannover

Stock Exchange Hamburg

Stock Exchange Munich

Stock Exchange Stuttgart

Registered Office and Company Headquarters

3 Dominion Place
Queanbeyan, NSW 2620
Australia

Telephone:  +61 2 6299 1592
Fax:  +61 2 6299 1698

Auditor

Grant Thornton Audit Pty Ltd
Level 19, 2 Market Street
Sydney, NSW 2000
Australia

 

Directors

Richard Caldwell, Managing Director
Ian Neal, Non-Executive Chairman 
Gordon Thompson, Non-Executive Director
Dr Robert (Rob) McIntyre, Non-Executive Director

 

Company Secretary

Kim Hogg

Investor Relations Contacts

Australia, Company Headquarters

Marine André Dyesol - Investor Relation Manager
Po Box 6212, Queanbeyan, NSW 2620

Telphone:  +61 2 6299 1592

Fax :+61 2 6299 1698                                  

Email:  mandre@dyesol.com

 


Germany
Eva Reuter
Dr Reuter Investor Relations
Mendelstraße 11 48149 Münster, Deutschland
Germany Telephone:  0049-251 / 980 1560
Email: e.reuter@dr-reuter.eu
Visit: SRI2 Capital Platform

 


Top 20 Shareholder Lists